TNF and rheumatoid arthritis: In contrast, for RA where the effectiveness of JAK inhibitors may be comparable to TNF antagonists, we observed a modestly higher risk of VTE with JAK inhibitors, likely related to an intrinsic prothrombotic potential of JAK inhibitors particularly at higher doses.